ODT’s Most-Read Stories This Week—Aug. 10

It’s top companies season, and the top three companies in this year’s report topped ODT site traffic this past week.

Zimmer Biomet was the digital darling over the past seven days, thanks to its public proposition to acquire OrthoGrid Systems, a privately-held company specializing in artificial intelligence (AI)-driven surgical guidance systems for total hip replacement. The deal includes HipAI, OrthoGrid’s AI-powered, fluoroscopy-based surgical assistance platform as well as two FDA-cleared orthopedic applications and more than 40 patents.

Stryker Corp., meanwhile, enticed cybervisitors by launching the “comprehensive and versatile” Pangea Plating System, which provides variable-angle plating for various patient populations. The system received U.S. Food and Drug Administration clearance last year. The Pangea Plating System is indicated for the internal fixation and stabilization of bone fractures, osteotomies and arthrodesis in normal and osteopenic bone. Offering an evidence-based design for implant fit, the system was designed to enhance plate fit and screw placement while elevating the plating market through anatomically contoured implants in patient populations with various fracture patterns. 

Not to be overshadowed by its rivals, DePuy Synthes prompted plenty of pageviews by launching its TriLEAP lower extremity anatomic plating system. The low-profile, procedure-specific titanium plates for foot and ankle surgeries received FDA 510(k) clearance for forefoot, midfoot, and hindfoot elective and trauma procedures in October 2023. TriLEAP features contoured and conventional titanium plates that accommodate various screw shaft options to allow for rescue screws. 

Other website favorites this past week included FloSpine’s new senior management hires and Osteal Therapeutics’ $50 million infusion of Series D funding.

1. Zimmer Biomet to Acquire OrthoGrid Systems

2. FloSpine Bolsters its Senior Executive Team

3. Stryker Unveils ‘Versatile’ Pangea Plating System

4. DePuy Synthes Rolls Out TriLEAP Lower Extremity Plates

5. Osteal Therapeutics Secures $50M in Series D Financing